| Literature DB >> 23933501 |
Yung-Ho Hsu1, Tso-Hsiao Chen, Yen-Cheng Chen, Chung-Yi Cheng, Yuh-Mou Sue, Jia-Rung Chen, Cheng-Hsien Chen.
Abstract
Urotensin II (UII) is a cyclic vasoactive peptide which is mainly expressed in kidneys. Although elevated plasma UII levels are associated with renal impairment, the influence of UII on renal injury is unclear. In this study, we monitored the influence of UII on gentamicin-induced apoptosis in rat tubular cells (NRK-52E). We found that UII significantly reduced gentamicin-induced apoptosis and apoptotic signals. Blocking endogenous UII secretion caused cells to be more susceptible to gentamicin. In gentamicin-treated mice, UII also expressed protective effect on renal tubular cells. UII was also found to induce prostacyclin (PGI2) production, which caused peroxisomal proliferator-activated receptor α (PPARα) activation as revealed by both PGI2 synthase siRNA transfection and piroxicam treatment. Blockage of PPARα by siRNA transfection inhibited UII-induced Akt phosphorylation and the antiapoptotic effect of UII. Our results suggest that UII can protect renal tubular cells from gentamicin-induced apoptosis through PGI2-mediated PPARα and Akt activation.Entities:
Keywords: 6-keto-PGF1α; 6-keto-prostaglandin F1α; Akt; Apoptosis; CKD; ESRD; IP; IV; PGI(2); PI; PI3K; PPARα; Peroxisome proliferator-activated receptor alpha (PPARα); Prostacyclin; TUNEL; UII; Urotensin II; chronic kidney disease; end-stage renal disease; intraperitoneal injection; intravenous injection; peroxisome proliferator-activated receptor alpha; phosphatidylinositol 3-kinase; propidium iodide; prostacyclin; terminal deoxynucleotidyl transferase dUTP nick end labeling; urotensin II
Mesh：
Substances：
Year: 2013 PMID： 23933501 DOI： 10.1016/j.mce.2013.07.028
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN： 0303-7207 Impact factor: 4.102